188 related articles for article (PubMed ID: 11718156)
21. [Second-line irinotecan chemotherapy in the treatment of metastatic colorectal cancers: phase III trials].
Mitry E; Ducreux M; Rougier P
Bull Cancer; 1998 Dec; Spec No():38-42. PubMed ID: 9932083
[TBL] [Abstract][Full Text] [Related]
22. European experience with irinotecan plus fluorouracil/folinic acid or mitomycin.
Khayat D; Gil-Delgado M; Antoine EC; Coeffic D; Benhammouda A; Grapin JP; Bastian G
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):64-7. PubMed ID: 9726094
[TBL] [Abstract][Full Text] [Related]
23. Irinotecan: toward clinical end points in drug development.
Pazdur R
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):13-21. PubMed ID: 9726086
[TBL] [Abstract][Full Text] [Related]
24. Medical care consumption in a phase III trial comparing irinotecan with infusional 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer after 5-FU failure.
Schmitt C; Blijham G; Jolain B; Rougier P; Van Cutsem E
Anticancer Drugs; 1999 Jul; 10(6):617-23. PubMed ID: 10885910
[TBL] [Abstract][Full Text] [Related]
25. Setting a new standard--irinotecan (Campto) in the second-line therapy of colorectal cancer: final results of two phase III studies and implications for clinical practice.
Cunningham D
Semin Oncol; 1999 Feb; 26(1 Suppl 5):1-5. PubMed ID: 10213008
[TBL] [Abstract][Full Text] [Related]
26. UFT plus calcium folinate/irinotecan in colorectal cancer.
Twelves C
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):51-4. PubMed ID: 10442362
[TBL] [Abstract][Full Text] [Related]
27. Methods for evaluating effects of an irinotecan + 5-fluorouracil/leucovorin (IFL) regimen in an orthotopic metastatic colorectal cancer model utilizing in vivo bioluminescence imaging.
Surguladze D; Steiner P; Prewett M; Tonra JR
Methods Mol Biol; 2010; 602():235-52. PubMed ID: 20012402
[TBL] [Abstract][Full Text] [Related]
28. Irinotecan may extend survival in people with metastatic colorectal cancer.
Oncology (Williston Park); 1998 Oct; 12(10):1512. PubMed ID: 9798204
[No Abstract] [Full Text] [Related]
29. US pivotal studies of irinotecan in colorectal carcinoma.
Pitot HC
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):48-53. PubMed ID: 9726091
[TBL] [Abstract][Full Text] [Related]
30. [Irinotecan in colorectal cancer].
Pozzo C; Cassano A; Barone C
Tumori; 2001; 87(1 Suppl 1):S49-50. PubMed ID: 11300023
[No Abstract] [Full Text] [Related]
31. Comparing irinotecan with best supportive care and infusional 5-fluorouracil: a critical evaluation of the results of two randomized phase III trials.
Wilke HJ
Semin Oncol; 1999 Feb; 26(1 Suppl 5):21-3. PubMed ID: 10213011
[TBL] [Abstract][Full Text] [Related]
32. A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy. V301 Study Group.
Cunningham D; Glimelius B
Semin Oncol; 1999 Feb; 26(1 Suppl 5):6-12. PubMed ID: 10213009
[TBL] [Abstract][Full Text] [Related]
33. [Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials].
Van Cutsem E; Peeters M
Bull Cancer; 1998 Dec; Spec No():33-7. PubMed ID: 9932082
[TBL] [Abstract][Full Text] [Related]
34. The role of irinotecan in colorectal cancer.
Saltz LB
Curr Oncol Rep; 1999; 1(2):155-60. PubMed ID: 11122813
[TBL] [Abstract][Full Text] [Related]
35. A risk-benefit assessment of irinotecan in solid tumours.
Siu LL; Rowinsky EK
Drug Saf; 1998 Jun; 18(6):395-417. PubMed ID: 9638386
[TBL] [Abstract][Full Text] [Related]
36. Irinotecan in the first-line treatment of colorectal cancer.
Saltz LB
Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):54-8. PubMed ID: 9726092
[TBL] [Abstract][Full Text] [Related]
37. Update on European adjuvant trials with irinotecan for colorectal cancer.
Douillard JY; Barbarot V; Bennouna J
Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):13-5. PubMed ID: 12014862
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer: Irinotecan therapy-following a trail of breadcrumbs?
Goldberg RM; O'Neil BH
Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):507-9. PubMed ID: 19713983
[TBL] [Abstract][Full Text] [Related]
39. Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy.
Aravantinos G; Skarlos DV; Kosmidis P; Georgoulias V; Sgouros I; Bafaloukos D; Androulakis N; Florou S; Fountzilas G
Crit Rev Oncol Hematol; 1999 Dec; 32(3):209-19. PubMed ID: 10633850
[No Abstract] [Full Text] [Related]
40. [A case of sigmoid colon cancer with temporary dysarthria associated with irinotecan].
Sogabe S; Yuki S; Takano H; Kobayashi Y; Nakatsumi H; Sasaki T; Kawamoto Y; Fukushima H; Iwanaga I; Uehata Y; Komatsu Y; Asaka M
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1375-7. PubMed ID: 21829085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]